Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder

por Cutler, Andrew J., Mattingly, Gregory W., Maletic, Vladimir
Publicado 2023

Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder

por Childress, Ann C., Newcorn, Jeffrey H., Cutler, Andrew J.
Publicado 2019

New Developments in the Treatment of Schizophrenia: An Expert Roundtable

por Kantrowitz, Joshua T, Correll, Christoph U, Jain, Rakesh, Cutler, Andrew J
Publicado 2023

Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate

por Childress, Ann C., Cutler, Andrew J., Patel, Maitrey, Oh, Charles
Publicado 2023

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Trea...

por Childress, Ann, Cutler, Andrew J., Marraffino, Andrea H., Bhaskar, Sailaja, Donnelly, Graeme
Publicado 2021

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study

por Childress, Ann C., Marraffino, Andrea, Cutler, Andrew J., Oh, Charles, Brams, Matthew N.
Publicado 2023

Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder

por Mattingly, Greg W., Childress, Ann C., Cutler, Andrew J., Estrada, José, Corliss, Meg
Publicado 2023

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder i...

por Childress, Ann C., Kollins, Scott H., Cutler, Andrew J., Marraffino, Andrea, Sikes, Carolyn R.
Publicado 2017

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom St...

por Childress, Ann C., Brams, Matthew N., Cutler, Andrew J., Donnelly, Graeme A.E., Bhaskar, Sailaja
Publicado 2020

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD

por Cataldo, Marc, Donnelly, Graeme, Cutler, Andrew J., Childress, Ann, Mikl, Jaromir, Bhaskar, Sailaja, Waxmonsky, James
Publicado 2022

Authors’ Reply to Singh and Balasundaram: Comment on “A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Relea...

por Nasser, Azmi, Hull, Joseph T., Liranso, Tesfaye, Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Childress, Ann
Publicado 2022

Annual costs among patients with major depressive disorder and the impact of key clinical events

por Cutler, Andrew J, Keyloun, Katelyn R, Higa, Sara, Park, Julie, Bonafede, Machaon, Gillard, Patrick, Jain, Rakesh
Publicado 2022

A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials

por Targum, Steven D, Houser, Celine, Northcutt, Joanne, Little, Jessica A, Cutler, Andrew J, Walling, David P
Publicado 2013

d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyse...

por Cutler, Andrew J., Suzuki, Katsumi, Starling, Brittney, Balakrishnan, Kanan, Komaroff, Marina, Meeves, Suzanne, Castelli, Mariacristina, Childress, Ann
Publicado 2023

Treatment Patterns During Major Depressive Episodes Among Patients with Major Depressive Disorder: A Retrospective Database Analysis

por Jain, Rakesh, Higa, Sara, Keyloun, Katelyn, Park, Julie, Bonafede, Machaon, Tung, Amy, Gillard, Patrick, Cutler, Andrew J.
Publicado 2022

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Ran...

por Childress, Ann C., Brams, Matthew, Cutler, Andrew J., Kollins, Scott H., Northcutt, Jo, Padilla, Americo, Turnbow, John M.
Publicado 2015

The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

por Nasrallah, Henry A., Earley, Willie, Cutler, Andrew J., Wang, Yao, Lu, Kaifeng, Laszlovszky, István, Németh, György, Durgam, Suresh
Publicado 2017

Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase...

por Cutler, Andrew J., Suzuki, Katsumi, Starling, Brittney, Balakrishnan, Kanan, Komaroff, Marina, Castelli, Mariacristina, Meeves, Suzanne, Childress, Ann C.
Publicado 2022

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

por Stacy, Mark, Sajatovic, Martha, Kane, John M., Cutler, Andrew J., Liang, Grace S., O'Brien, Christopher F., Correll, Christoph U.
Publicado 2019

Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study

por Cutler, Andrew J., Caroff, Stanley N., Tanner, Caroline M., Shalhoub, Huda, Lenderking, William R., Pagé, Véronique, Franey, Ericha, Yonan, Chuck
Publicado 2021